Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance — Miriam Galbusera (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance
Shared by
Giuseppe Remuzzi
In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance
Article
2011
en
Authors
+6 more
MG
Miriam Galbusera
SG
Silvia Gastoldi
FB
Federica Banterla
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2009
Atypical Hemolytic–Uremic Syndrome
Marina Noris
,
Giuseppe Remuzzi
Article
2016
Genetic Atypical Hemolytic-Uremic Syndrome
Marina Noris
,
Elena Bresin
,
Caterina Mele
,
Giuseppe Remuzzi
Article
2009
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Mieke Delvaeye
,
Marina Noris
,
Astrid De Vriese
,
Charles T. Esmon
,
Naomi L. Esmon
,
Gary Ferrell
,
Jurgen Del‐Favero
,
Stéphane Plaisance
,
Bart Claes
,
Diether Lambrechts
,
Carla Zoja
,
Giuseppe Remuzzi
,
Edward M. Conway
Article
2012
C5a/C5aR interaction mediates complement activation and thrombosis on endothelial cells in atypical hemolytic uremic syndrome (aHUS)
Sara Gastoldi
,
Marina Noris
,
Paolo Macor
,
Francesco Tedesco
,
Federica Banterla
,
Elena Bresin
,
Roberta Donadelli
,
Giuseppe Remuzzi
,
Miriam Galbusera
Article
2007
Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome
David Kavanagh
,
Anna Richards
,
Véronique Frémeaux‐Bacchi
,
Marina Noris
,
Timothy H.J. Goodship
,
Giuseppe Remuzzi
,
John P. Atkinson
Discussion(0)
No comments yet. Be the first to comment.